SIGNATUREFD, LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
SIGNATUREFD, LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$16,607
-20.6%
671
-9.2%
0.00%
-100.0%
Q2 2023$20,928
+18.8%
739
-3.7%
0.00%
Q1 2023$17,618
-36.0%
767
-21.8%
0.00%
-100.0%
Q4 2022$27,546
-1.6%
981
-2.2%
0.00%0.0%
Q3 2022$28,000
+133.3%
1,003
+92.5%
0.00%
Q2 2022$12,000
+300.0%
521
+337.8%
0.00%
Q1 2022$3,000
+200.0%
119
+164.4%
0.00%
Q4 2021$1,000
-66.7%
45
-38.4%
0.00%
Q3 2021$3,000
-70.0%
73
-59.0%
0.00%
Q2 2021$10,000
+66.7%
178
+61.8%
0.00%
Q1 2021$6,000
+100.0%
110
+50.7%
0.00%
Q4 2020$3,0000.0%730.0%0.00%
Q3 2020$3,000
+50.0%
73
+92.1%
0.00%
Q2 2020$2,000
+100.0%
38
+5.6%
0.00%
Q1 2020$1,000
-66.7%
36
-33.3%
0.00%
Q4 2019$3,000
+200.0%
54
+200.0%
0.00%
Q3 2019$1,000
-50.0%
18
-63.3%
0.00%
Q2 2019$2,0000.0%49
+75.0%
0.00%
Q1 2019$2,000280.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Flagship Ventures 2007 General Partner LLC 1,930,369$118,428,00083.56%
Third Rock Ventures, LLC 3,070,090$188,350,00021.97%
Opaleye Management Inc. 113,500$6,963,225,0005.43%
BB BIOTECH AG 1,890,521$115,983,0004.72%
Eventide Asset Management 431,600$26,479,0003.70%
Atika Capital Management LLC 54,000$3,313,0002.55%
Cormorant Asset Management, LP 100,000$6,135,0001.26%
BRIDGER MANAGEMENT, LLC 220,099$13,503,0000.92%
Ghost Tree Capital, LLC 20,000$1,227,0000.67%
HAMILTON LANE ADVISORS LLC 27,544$1,690,0000.55%
View complete list of AGIOS PHARMACEUTICALS INC shareholders